These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6977775)

  • 1. Increased responses to lymphokines are correlated with preleukemia in mice inoculated with Moloney leukemia virus.
    Lee JC; Ihle JN
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7712-6. PubMed ID: 6977775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens.
    Lee JC; Horak I; Ihle JN
    J Immunol; 1981 Feb; 126(2):715-22. PubMed ID: 6969759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
    Ihle JN; Lee JC; Rebar L
    J Immunol; 1981 Dec; 127(6):2565-70. PubMed ID: 6795277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell recognition of Moloney sarcoma virus proteins. II. Phenotypes of the different lymphocyte subpopulations producing and responding to blastogenic factors and their relative frequencies during tumor regression.
    Lee JC; Enjuanes L; Cicurel L; Ihle JN
    J Immunol; 1981 Jul; 127(1):78-83. PubMed ID: 6972414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic immune stimulation is required for Moloney leukaemia virus-induced lymphomas.
    Lee JC; Ihle JN
    Nature; 1981 Jan; 289(5796):407-9. PubMed ID: 6970336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of sensitivity to moloney leukemia virus in mice. VI. Involvement of virus-specific T helper cells collaborating with B cells.
    Boyer B; Debré P; Seman M; Zilberfarb V; Lévy JP
    Eur J Immunol; 1982 Aug; 12(8):692-7. PubMed ID: 6216112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
    Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
    Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control.
    Debre P; Gisselbrecht S; Boyer B; Levy JP
    Blood Cells; 1981; 7(2):301-11. PubMed ID: 6975141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moloney virus (M-MuLV) leukemogenesis: virus spread, antibody production and antigenic expression in neonatally virus-inoculated young mice.
    Asjö B; Fenyö EM; Klein G
    Int J Cancer; 1981 Jul; 28(1):65-70. PubMed ID: 7309282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1981 Apr; 126(4):1478-84. PubMed ID: 6970777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
    Caulfield MJ; Cerny J
    J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291
    [No Abstract]   [Full Text] [Related]  

  • 17. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
    J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors.
    Varesio L; Herberman RB; Gerson JM; Holden HT
    Int J Cancer; 1979 Jul; 24(1):97-102. PubMed ID: 314424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of natural killer cell activity in MoLV leukemogenesis: evidence for tumor-cell-mediated suppression.
    Ofir R; Weinstein Y; Rager-Zisman B
    Nat Immun Cell Growth Regul; 1988; 7(2):77-86. PubMed ID: 2842667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.